SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2661Supergen (SUPG) off 15% as Dacogen whiffs in AML. But partner Eisai is going totuck-6/30/2010
2660EpiCept Announces Pricing of Public Offering Date : 06/28/2010 @ 2:30AM Source mlkr-6/29/2010
2659EPCT. Nice promise to whoever bought in. Go into the deal and you can sell tomorrkrw-6/29/2010
2658Very similar to NBS Neostem in the friday session. NBS crashed on similarly discRockyBalboa-6/28/2010
2657EpiCept, which actually got EU approval for Ceplene, is off 36% to a buck on a tuck-6/28/2010
2656Isotecknica (ISA.TO)off 33%. The June 28 meeting of the Dermatology and OphthalmD.Lu-6/23/2010
2655ZIOP: Day's range: $3.28-3.59; 52 weeks range: 1.25-6.30.. doesnt loomlkr-6/22/2010
2654Thanks, tuck!RockyBalboa-6/22/2010
2653I wasn't being entirely clear . . . $20 million for glioblastoma. Ttuck-6/21/2010
2652<i> I'd say there's a greater chance the FDA has changed the rulestom pope16/21/2010
2651I guess the end point must be pretty important and the data so far doesn't afred hayes-6/21/2010
2650pardon me for being a bit more cynical than usual, but if this is true, why woulIan@SI-6/21/2010
2649Well, I just bought some at 3.42, will not add if it opens weak. I hope ZIOP matom pope-6/21/2010
2648Exelixis (EXEL) gets XL184 back for the second time, sending shares down by 16%.tuck16/21/2010
2647Re: AFFY's drop . . . The pre-dialysis subgroup -- which was prosptuck-6/21/2010
2646ZIOP: Down 1.15 to 3.70s despite this: go and figure it out by reading between mlkr-6/21/2010
2645Indeed. Unless the delay is obscuring something dire and some very smart people tom pope-6/21/2010
2644Looks way overdone. Basic case intact unless I'm missing something...fred hayes-6/21/2010
2643ZIOP (which I own) down over 25% finance.yahoo.com Key para <i>In a rectom pope-6/21/2010
2642Strange dropp $8 now .. amazing drop despite end point met according to co. Tmlkr-6/21/2010
2641-65% AFFY UPDATE 1-Affymax anemia drug meets goal in late-stage trials Mon Jun 2RockyBalboa-6/21/2010
2640ADLR: 1.25 Adolor says pain drugs failed in midstage trial Adolor says 2 pain mlkr-6/18/2010
2639Adolor off 18% AH on failure of two delta opioid receptor agonists in one trial:tuck-6/17/2010
2638"Speaking of recent financing, DSCO off 23% on another one. Is it enough totuck-6/17/2010
2637CRIS and ROCHE backed trial result not so good it seems Curis Tumbles As Roche mlkr-6/16/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News